3649 results for «684»
3649 results
EuroPCR 2023 Welcome Ceremony
16 May 2023 – From EuroPCR 2023
As we celebrate the 30th anniversary of primary PCI for STEMI this year, follow the retrospective of this major advance in interventional cardiology, before listening to William Wijns, Jean Fajadet and their guests take stock of the current STEMI care worldwide at this opening ceremony which launches...
Defining together the ideal TAVI platform of the future
16 May 2023 – From EuroPCR 2023
How to successfully plan and access a TAVI procedure using ultrasound guidance? How to close a TAVI procedure using suture-based vessel closure devices? How to manage vascular complications during and after TAVI procedures? Join the speakers in this brainstorming session and imagine what tomorrow's ideal TAVI...
Coronary Sinus Reducer: insights into treating refractory angina patients with obstructive and non-obstructive coronary artery disease
16 May 2023 – From EuroPCR 2023
Watch this session to learn how Sinus Reducer may relieve angina by increasing pressure in the coronary sinus, and how it was associated with significant improvement in symptoms and quality of life, as long as the different steps of this simple procedure are dully followed and...
Primary percutaneous pulmonary intervention (pPPI) of acute pulmonary embolism with computer-aided mechanical aspiration
16 May 2023 – From EuroPCR 2023
As there is a need for more awareness, training and data on primary percutaneous pulmonary intervention, watch this session to learn from shared pioneering experience!
Management of mitral regurgitation patients undergoing TMVI screening
13 Jan 2022
This study's results emphasise the strengths and limitations of transcatheter mitral valve implantation (TMVI) as a novel and promising therapy providing predictable elimination of MR in most patients, by S. Ludwig et al.
5-year outcomes after transcatheter or surgical aortic valve replacement in low-risk patients with aortic stenosis (Evolut Low Risk)
01 Apr 2025
Yohei Ohno provides his takeaways from the results of the Evolut Low Risk trial which was presented by Michael J. Reardon during the ACC.25 in Chicago.
Author
PCR STATEMENT on the 2-year clinical outcomes from the Evolut low risk trial
18 May 2021
Transcatheter aortic valve implantation (TAVI) offers an effective, less invasive therapeutic alternative to surgical aortic valve replacement in patients with symptomatic, severe aortic stenosis. Although TAVI is demonstrated to be superior to medical therapy or surgery in patients who are at prohibitive or high risk for...
30 years of primary PCI – a tale of perseverance
16 May 2023
Over the last 30 years, primary PCI (pPCI) has evolved from an experimental ‘rescue’ intervention to an essential routine procedure – performed daily in cathlabs around the world – which is responsible for saving millions of lives. However, its path to success was far from smooth.
Transcatheter vs surgical aortic valve replacement in aortic stenosis patients at low surgical risk: 3-year outcomes from the Evolut Low Risk trial
05 Mar 2023
Luigi Biasco provides his take on the clinical trial presented by John K. Forrest from Yale University School of Medicine, New Haven, Connecticut, USA during the 2023 ACC/WCC annual congress held in New Orleans, Louisiana.
Author
